ASCO 2022 Conference Coverage

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

ASCO 2022 Conference Coverage

Breast
Lung
GI
GU
Skin
GYN
Head & Neck
Leukemia
Lymphoma
Myeloma
MDS and MPN
Sarcoma

Playback speed

10 seconds

ASCO 2022 on RELATIVITY-047 Trial: Nivolumab + Relatlimab vs. Nivo in 1L Metastatic/Unresectable Melanoma: OS & ORR by Key Subgroups

By ASCO 2022 Conference Coverage FEATURING Piotr Rutkowski

1,104 views

June 9, 2022

Comments 0

Unmet Needs for Patients With HR+, HER2- Early Breast Cancer at a Hi…

Feat. H. Rugo

Progression on First-Line Therapy in HR+, HER2- MBC: Treatments and …

Feat. J. O’Shaughnessy

Skin

ASCO 2022 Updates on DREAMseq (Doublet, Randomized Evaluation in Adv…

ASCO 2022 Conference Coverage

M. Atkins

215 views

Lecture Summary - ASCO 2022 on Anti-PD-1 Antibody: Plus One or Plus …

ASCO 2022 Conference Coverage

A. Daud

15 views

ASCO 2022 on Anti-PD-1 Antibody: Plus One or Plus Two

ASCO 2022 Conference Coverage

A. Daud

270 views

ASCO 2022 Nivo + Rela vs. Nivo in Previously Untreated Metastatic/Un…

ASCO 2022 Conference Coverage

E. Lipson

336 views

Lecture Summary - ASCO 2022 Meta-Analysis of Randomized Phase II-III…

ASCO 2022 Conference Coverage

P. Francesco Ferrucci

11 views

ASCO 2022 Meta-Analysis of Randomized Phase II-III Trials Evaluating…

ASCO 2022 Conference Coverage

P. Francesco Ferrucci

110 views

ASCO 2022 on the Role of Metastasectomy in Advanced BRAF+ Melanoma D…

ASCO 2022 Conference Coverage

K. Orlova

300 views

ASCO 2022 on ARTISTRY-6 Trial: Nemvaleukin Alfa Monotherapy in Advan…

ASCO 2022 Conference Coverage

J. Weber

118 views

Lecture Summary - ASCO 2022 on ARTISTRY-6 Trial: Nemvaleukin Alfa Mo…

ASCO 2022 Conference Coverage

J. Weber

20 views

Lecture Summary - ASCO 2022 on Long-Term Toxicities With Immune Chec…

ASCO 2022 Conference Coverage

J. Tong

321 views

ASCO 2022 on Long-Term Toxicities With Immune Checkpoint Inhibitor i…

ASCO 2022 Conference Coverage

J. Tong

513 views

ASCO 2022 Primary Ipi/Nivo Followed by Adjuvant Nivo in Pts With Loc…

ASCO 2022 Conference Coverage

E. Cocorocchio

207 views

ASCO 2022 on Survival Update of Neoadjuvant Ipi + Nivo in Macroscopi…

ASCO 2022 Conference Coverage

J. Versluis

40 views

ASCO 2022 Phase II SECOMBIT Study on Optimal Treatment Sequencing in…

ASCO 2022 Conference Coverage

P. Ascierto

110 views

Lecture Summary - ASCO 2022 on Thromboembolism and Association With …

ASCO 2022 Conference Coverage

T. Sussman

13 views

ASCO 2022 on Thromboembolism and Association With Survival in Pts Wi…

ASCO 2022 Conference Coverage

T. Sussman

110 views

ASCO 2022: Real-World Evaluation of the Association Between Baseline…

ASCO 2022 Conference Coverage

Z. Eroglu

130 views

ASCO 2022 on ImmunoCobiVem Study Interim Analysis: The Efficacy & Sa…

ASCO 2022 Conference Coverage

E. Livingstone

124 views

Lecture Summary - ASCO 2022 Nivolumab + Relatlimab vs. Nivo in 1L Me…

ASCO 2022 Conference Coverage

P. Rutkowski

18 views

ASCO 2022 on RELATIVITY-047 Trial: Nivolumab + Relatlimab vs. Nivo i…

ASCO 2022 Conference Coverage

P. Rutkowski

1.1K views

Lecture Summary - ASCO 2022 Long-Term Survival in Advanced Melanoma …

ASCO 2022 Conference Coverage

P. Rutkowski

13 views

ASCO 2022 Long-Term Survival in Advanced Melanoma for Pts Treated Wi…

ASCO 2022 Conference Coverage

P. Rutkowski

132 views

ASCO 2022 Analysis of the Effect of Systemic Corticosteroids on Surv…

ASCO 2022 Conference Coverage

A. Ikeguchi

58 views